Skip to main content
WPD Pharmaceuticals Inc. logo

WPD Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · WBIO ISIN · CA92941F2044 LEI · 549300YZKU39UPMSYY11 CSE Financial and insurance activities
Filings indexed 162 across all filing types
Latest filing 2024-05-16 Regulatory Filings
Country CA Canada
Listing CSE WBIO

About WPD Pharmaceuticals Inc.

https://www.wpdpharmaceuticals.com/

WPD Pharmaceuticals Inc. is a biotechnology company that currently maintains no active business operations. Its sole asset is a minority equity stake (approximately 7%) in its former subsidiary, WPD Pharmaceuticals Sp. zo.o., following a restructuring in November 2022. The Polish entity, which WPD Pharmaceuticals Inc. holds shares in, is a biotechnology research and development company focused on oncology. Its core activities involve the research and development of medicinal products, including biological compounds and small molecules, primarily targeting targeted therapy for brain glioma and other central nervous system cancers.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings
2024-05-16 English
News release - English.pdf
Regulatory Filings
2024-05-16 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2024-05-08 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2024-05-08 English
Annual MD&A - English.pdf
Regulatory Filings
2024-05-08 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings
2024-05-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.